Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals

Inclusion Criteria: * Be able to give written informed consent and to consume the investigational product daily for the duration of the study. * Healthy males and females aged ≥ 55 and ≤ 75 years old. * Body-mass index between 18.5 and 35.0 kg/m2 * Is free-living (living in a private home, alone or with family, and able to maintain their health and hygiene without assistance). * Have age-associated memory impairment (AAMI) based on the following National Institute of Mental Health criteria, specified as scoring: 1. Absence of dementia as determined by a score of \>24 on the Mini Mental State Examination (MMSE). 2. ≤29 or ≤9 on the VPA I and II portions of the Wechsler Memory Scale IV, respectively 3. A score on the MAC-Q of ≥25. * Is in general good health, as determined by the investigator * Ability to comply and understand the cognitive function practice tests * Willing to maintain their habitual diet and exercise routines. * Willing to maintain consistent sleep duration the evening before study visits. Exclusion Criteria: * Use of medications or supplements known to alter cognitive function within past 2 weeks * Abnormal clinical laboratory test that may affect study outcome. * History or presence of clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, gastrointestinal, pancreatic, or neurological disorders (including sleep disorders, head injuries, Alzheimer's disease, Parkinson's disease, stroke, inflammatory brain disease * History or presence of cancer, except nonmelanoma skin cancer * Uncontrolled hypertension/diabetes * History of depression within past 24 months or use of psychotropic medications within 1 month of screening * Planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling) during the duration of the study. * History within previous 12 months of alcohol or substance abuse. * History of heavy smoking (\>1 pack/day) within past 3 months